Cite
HARVARD Citation
Sheikh, I. et al. (2022). Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient. Pediatric blood & cancer. 69 (3), p. n/a. [Online].